← Back to headlines
TD Cowen Downgrades Cellebrite Citing Market Contraction Despite Revenue Growth
TD Cowen has downgraded Cellebrite (CLBT), citing market contraction as the reason despite the company's strong recurring revenue growth.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
